TrialThe European respiratory journal2025

Pirfenidone in post-COVID-19 pulmonary fibrosis (FIBRO-COVID): a phase 2 randomised clinical trial.

Guadalupe Bermudo-Peloche et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.